Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21272265 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety
Conditions: Hypoactive Sexual Desire Disorder (DSM-IV-TR Defined);   Sexual Interest/Arousal Disorder (DSM-5 Defined)
Intervention: Drug: bupropion, Lorexys low-dose, Lorexys moderate-dose

Indicates status has not been verified in more than two years